AI assistant
T42 IOT TRACKING SOLUTIONS PLC — Director's Dealing 2019
Jan 16, 2019
7945_rns_2019-01-16_bc595d50-94c5-49c4-8a61-aa1b8d441483.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3015N
Starcom PLC
16 January 2019
Starcom Plc
("Starcom" or the "Company")
Director Declaration
Starcom (AIM: STAR) announces, in accordance with Rule 17 and paragraph (g), Schedule Two of the AIM Rules for Companies, the following disclosures which were inadvertently omitted from the Company's Admission Document dated 19 February 2013 in relation to Michael Rosenberg, the Company's Chairman:
In March 2004, he resigned as a director of E-Daily Limited, a company incorporated in England and Wales which was put into compulsory liquidation in November 2004 and was dissolved in November 2006.
In December 2003, he resigned as a director of Kioskpoint Limited, a company incorporated in England and Wales which was put into administration in March 2004 and was dissolved in December 2004.
He was a director of Scintronix Limited, a company incorporated in Scotland, to which a receiver was appointed in 1988 and which was dissolved in June 2006.
**ENDS**
Enquiries:
| Starcom Plc Michael Rosenberg, Chairman |
07785 727 595 |
| Avi Hartmann, CEO | +972 5447 35663 |
| Northland Capital Partners Limited (Nominated Adviser and Broker) | 020 3861 6625 |
| Matthew Johnson / Edward Hutton (Corporate Finance) Rob Rees (Sales and Broking) |
|
| Peterhouse Capital Limited (Joint Broker) | 020 7469 0930 |
| Lucy Williams / Charles Goodfellow / Eran Zucker | |
| Leander PR (Financial PR) | 07795 168 157 |
| Christian Taylor-Wilkinson |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
RDNUNSVRKAAAAAR